New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

by Lauren Nichola Colley,The ConversationCredit: Pixabay/CC0 Public DomainGoing for a walk is always a good idea. Perhaps, if you are lucky enough, this might be a hike along ragged cliffs or tr
Oncology March 22,2024
Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

Going for a walk wasn't really a thing 300 years ago—the Victorians turned it into a popular pastime

by Lauren Nichola Colley,The ConversationCredit: Pixabay/CC0 Public DomainGoing for a walk is always a good idea. Perhaps, if you are lucky enough, this might be a hike along ragged cliffs or tr
Oncology March 22,2024
ADHD drug shortages: What to expect if you take Vyvanse and can't access your usual dose

ADHD drug shortages: What to expect if you take Vyvanse and can't access your usual dose

by Alison Poulton,The ConversationCredit: Pixabay/CC0 Public DomainImagine you or your child has attention deficit hyperactivity disorder (ADHD), and after several weeks, or even months, you&#39
Breakthroughs March 22,2024
ADHD drug shortages: What to expect if you take Vyvanse and can't access your usual dose

ADHD drug shortages: What to expect if you take Vyvanse and can't access your usual dose

by Alison Poulton,The ConversationCredit: Pixabay/CC0 Public DomainImagine you or your child has attention deficit hyperactivity disorder (ADHD), and after several weeks, or even months, you&#39
Breakthroughs March 22,2024
Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene
Oncology March 22,2024
Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene
Oncology March 22,2024
'Suspended animation' drug could aid organ transplantation and survival from traumatic injury

'Suspended animation' drug could aid organ transplantation and survival from traumatic injury

by eLifeSNC80 uptake and activity at the delta opioid receptor. a. Distribution of SNC80 in Xenopus tadpoles after 1 and 2 hours of compound exposure. b. Uptake of SNC80 in the tadpole skeletal m
Breakthroughs March 22,2024
'Suspended animation' drug could aid organ transplantation and survival from traumatic injury

'Suspended animation' drug could aid organ transplantation and survival from traumatic injury

by eLifeSNC80 uptake and activity at the delta opioid receptor. a. Distribution of SNC80 in Xenopus tadpoles after 1 and 2 hours of compound exposure. b. Uptake of SNC80 in the tadpole skeletal m
Breakthroughs March 22,2024
PCSK9 inhibitor access remains a significant barrier, leaving patients at risk for heart attacks and strokes

PCSK9 inhibitor access remains a significant barrier, leaving patients at risk for heart attacks and strokes

by Family Heart FoundationCredit: Pixabay/CC0 Public DomainA new study published inCirculation: Cardiovascular Quality and Outcomesfrom the Family Heart Foundation—a patient-centered resea
Cardiovascular Diseases March 22,2024
PCSK9 inhibitor access remains a significant barrier, leaving patients at risk for heart attacks and strokes

PCSK9 inhibitor access remains a significant barrier, leaving patients at risk for heart attacks and strokes

by Family Heart FoundationCredit: Pixabay/CC0 Public DomainA new study published inCirculation: Cardiovascular Quality and Outcomesfrom the Family Heart Foundation—a patient-centered resea
Cardiovascular Diseases March 22,2024
Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro
Oncology March 22,2024
Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro
Oncology March 22,2024
FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer

FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer

by Denise Heady,University of California, Los AngelesKaplan–Meier estimates of overall survival (A) and progression-free survival (B) NALIRIFOX=liposomal irinotecan in combination with fluoroura
Oncology March 22,2024
FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer

FDA approval of 4-drug combination for front-line treatment of metastatic pancreatic cancer

by Denise Heady,University of California, Los AngelesKaplan–Meier estimates of overall survival (A) and progression-free survival (B) NALIRIFOX=liposomal irinotecan in combination with fluoroura
Oncology March 22,2024
FDA seizes more than 1.4 million illegal vaping products

FDA seizes more than 1.4 million illegal vaping products

by Dennis ThompsonFederal agents have seized more than 1.4 million illegal vaping products being smuggled into the United States from China.A three-day operation at Los Angeles International Airport r
Public Health & Prevention March 22,2024
FDA seizes more than 1.4 million illegal vaping products

FDA seizes more than 1.4 million illegal vaping products

by Dennis ThompsonFederal agents have seized more than 1.4 million illegal vaping products being smuggled into the United States from China.A three-day operation at Los Angeles International Airport r
Public Health & Prevention March 22,2024
Asthma inhaler switch in 2024 could leave some patients scrambling

Asthma inhaler switch in 2024 could leave some patients scrambling

by Carole Tanzer MillerA popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.GSK, maker of the branded inha
Pulmonology March 22,2024
Asthma inhaler switch in 2024 could leave some patients scrambling

Asthma inhaler switch in 2024 could leave some patients scrambling

by Carole Tanzer MillerA popular asthma inhaler is being discontinued Jan. 1, fueling concerns that patients may have trouble getting insurance coverage for alternatives.GSK, maker of the branded inha
Pulmonology March 22,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com